Know-How

Stago’s VASP Assay Used For P2Y12 Biomarker Studies

Stago’s VASP Assay Used For P2Y12 Biomarker Studies
October 1, 2010, Parsippany, NJ, USA – The VASP flow cytometry assay kit from Diagnostica Stago, Inc. (Stago), examines platelet responsiveness to specific platelet ADP receptor (P2Y12) antagonists and their in vitro effects, and may also be used as a biomarker to track hemostatic effects of P2Y12 inhibitors such as clopidogrel (PLAVIX) and other drugs targeting this receptor. Additionally, as the assay is P2Y12-specific and independent of other platelet receptors, aspirin and abciximab (ReoPro®) do not interfere. Additionally, VASP can be used to perform research on genetic causes of P2Y12 functional deficiency.

Introducing Qualiris by Stago: A New Hemostasis Quality Assurance Program Focused on Your Result

Introducing Qualiris by Stago: A New Hemostasis Quality Assurance Program Focused on Your Result
August 20, 2010, Parsippany, NJ, USA – Diagnostica Stago, Inc. is proud to introduce the new Qualiris by Stago dedicated hemostasis proficiency testing program. This international quality assurance program (QAP) is an ideal complement to an existing quality program by offering the broadest range of routine and specialty proficiency testing parameters, all with the flexibility to meet your laboratory’s needs. Qualiris is a simple web-based system; participant results are compared both nationally and internationally for maximum statistical confidence no matter what hemostasis panel is tested.